325 related articles for article (PubMed ID: 26526578)
1. Genetic polymorphisms in MMP 2, 3, 7, and 9 genes and the susceptibility and clinical outcome of cervical cancer in a Chinese Han population.
Xie B; Zhang Z; Wang H; Chen Z; Wang Y; Liang H; Yang G; Yang X; Zhang H
Tumour Biol; 2016 Apr; 37(4):4883-8. PubMed ID: 26526578
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in MMP 2, 3 and 9 genes and the susceptibility of osteosarcoma in a Chinese Han population.
Cui Y; Zhu JJ; Ma CB; Cui K; Wang F; Ni SH; Zhang ZY
Biomarkers; 2016; 21(2):160-3. PubMed ID: 26754027
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.
Zhang L; Xi RX; Zhang XZ
Genet Mol Res; 2015 May; 14(2):4616-24. PubMed ID: 25966235
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of Matrix Metalloproteinases Genes MMP1, MMP2, MMP3, and MMP7 and the Risk of Varicose Veins of Lower Extremities.
Shadrina AS; Smetanina MA; Sevost'yanova KS; Shevela AI; Seliverstov EI; Zakharova EA; Voronina EN; Ilyukhin EA; Zolotukhin IA; Kirienko AI; Filipenko ML
Bull Exp Biol Med; 2017 Sep; 163(5):650-654. PubMed ID: 28944430
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
7. Impact of
Durmanova V; Javor J; Parnicka Z; Minarik G; Ocenasova A; Vaseckova B; Reznakova V; Kralova M; Hromadka T; Shawkatova I
Mediators Inflamm; 2021; 2021():5573642. PubMed ID: 33986628
[TBL] [Abstract][Full Text] [Related]
8. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
Sharma KL; Misra S; Kumar A; Mittal B
Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
Peng B; Cao L; Ma X; Wang W; Wang D; Yu L
Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147
[TBL] [Abstract][Full Text] [Related]
10. Association between matrix metalloproteinase gene polymorphisms and development of ischemic stroke.
Hao Y; Tian S; Sun M; Zhu Y; Nie Z; Yang S
Int J Clin Exp Pathol; 2015; 8(9):11647-52. PubMed ID: 26617904
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
Woo M; Park K; Nam J; Kim JC
J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
[TBL] [Abstract][Full Text] [Related]
12. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
[TBL] [Abstract][Full Text] [Related]
13. The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection.
Singh N; Hussain S; Sharma U; Suri V; Nijhawan R; Bharadwaj M; Sobti RC
Tumour Biol; 2016 Apr; 37(4):5295-303. PubMed ID: 26561467
[TBL] [Abstract][Full Text] [Related]
14. Interactions of central obesity with rs3918242 on risk of non-alcoholic fat liver disease: a preliminary case-control study.
Wu P; Hua Y; Tan S; Li M; Shu Y; Fang G
Int J Clin Exp Pathol; 2015; 8(4):4165-70. PubMed ID: 26097608
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival.
González-Arriaga P; Pascual T; García-Alvarez A; Fernández-Somoano A; López-Cima MF; Tardón A
BMC Cancer; 2012 Mar; 12():121. PubMed ID: 22455335
[TBL] [Abstract][Full Text] [Related]
16. The association of polymorphisms in promoter region of MMP2 and MMP9 with recurrent spontaneous abortion risk in Chinese population.
Li L; Liu J; Qin S; Li R
Medicine (Baltimore); 2018 Oct; 97(40):e12561. PubMed ID: 30290617
[TBL] [Abstract][Full Text] [Related]
17. MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis.
Tao L; Li Z; Lin L; Lei Y; Hongyuan Y; Hongwei J; Yang L; Chuize K
Genet Test Mol Biomarkers; 2015 Oct; 19(10):548-55. PubMed ID: 26301605
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the matrix metalloproteinase genes are associated with essential hypertension in a Caucasian population of Central Russia.
Moskalenko M; Ponomarenko I; Reshetnikov E; Dvornyk V; Churnosov M
Sci Rep; 2021 Mar; 11(1):5224. PubMed ID: 33664351
[TBL] [Abstract][Full Text] [Related]
19. Association of matrix metalloproteinases (MMP2, MMP7 and MMP9) genetic variants with left ventricular dysfunction in coronary artery disease patients.
Mishra A; Srivastava A; Mittal T; Garg N; Mittal B
Clin Chim Acta; 2012 Oct; 413(19-20):1668-74. PubMed ID: 22664146
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility.
Yi YC; Chou PT; Chen LY; Kuo WH; Ho ES; Han CP; Yang SF
Clin Chem Lab Med; 2010 Mar; 48(3):337-44. PubMed ID: 20113256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
